Summary of European Commission Decisions on authorisations for the placing on the market for the use and/or for use of substances listed in Annex XIV to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) (Published pursuant to Article 64(9) of Regulation (EC) No 1907/2006 (OJ L 396, 30.12.2006, p. 1.)) (Text with EEA relevance) 2022/C 420/05
Date: 2022-11-03
Institutions: Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs, European Commission
Subjects: animal disease, chemical product, health control, health risk, market approval, marketing standard, medical device, polishing and scouring preparations, veterinary medicinal product, veterinary medicine








C_2022420EN.01000501.xml










3.11.2022   


EN


Official Journal of the European Union


C 420/5






Summary of European Commission Decisions on authorisations for the placing on the market for the use and/or for use of substances listed in Annex XIV to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH)


(Published pursuant to Article 64(9) of Regulation (EC) No 1907/2006 (1))

(Text with EEA relevance)
(2022/C 420/05)

Decision granting an authorisation













Reference of the decision (2)



Date of decision


Substance name


Holder(s) of the authorisation


Authorisation number


Authorised use


Date of expiry of review period


Reasons for the decision




C(2022) 7525


26 October 2022


4-(1,1,3,3-Tetra methylbutyl)phenol, ethoxylated
(4-tert-OPnEO)
EC No: -, CAS No:-
4-Nonylphenol, branched and linear, ethoxylated (4-NPnEO)
EC No: -, CAS No:-


Idexx Montpellier SAS, 326, rue de la Galera, 34090, Montpellier, France


REACH/22/43/0


4-tert-OPnEO as detergent in the technical manufacturing of in vitro diagnostic veterinary ELISA Plate tests (plate coating) to prevent the non-specific binding of unwanted macromolecules


4 January 2033


In accordance with Article 60(4) of Regulation (EC) No 1907/2006, the socio-economic benefits outweigh the risk to human health and the environment from the uses of the substance and there are no suitable alternative substances or technologies.




REACH/22/43/1


Formulation of 4-tert-OPnEO in the manufacture of sample diluents and standard solutions used in in vitro diagnostic veterinary ELISA Plate tests used for the detection of infectious diseases in livestock and poultry




Idexx Montpellier SAS


REACH/22/43/2


4-tert-OPnEO in in vitro diagnostic veterinary products (SNAP tests and ELISA Plate tests) as an ingredient in the wash solutions, sample diluents, control solutions, conjugate solutions, SNAP wash solutions, tissue soaking buffers and detection solutions




Idexx B.V., Scorpius 60 Building F, 2132 LR Hoofddorp, Netherlands


REACH/22/43/3


 




Idexx Montpellier SAS


REACH/22/43/4


4-NPnEO in in vitro diagnostic veterinary products (SNAP tests and ELISA Plate tests) as an ingredient in the wash solutions, sample diluents, control solutions, conjugate solutions, SNAP wash solutions, tissue soaking buffers and detection solutions




Idexx B.V.


REACH/22/43/5






(1)  OJ L 396, 30.12.2006, p. 1.

(2)  The decision is available on the European Commission website at: Authorisation (europa.eu).